Home blood-collection device supplier Boston Microfluidics has secured LabCorp as an investor in a $17.5m round that was led by Anzu Partners.

US-based diagnostics technology manufacturer Boston Microfluidics has received $17.5m in a series A round led by venture capital firm Anzu Partners and backed by life sciences research services provider LabCorp. Boston Microfluidics supplies blood collection devices that enable patients to take samples at home rather than relying on visits to a doctor’s surgery. LabCorp already…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.